Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Other Working Capital Changes (2018 - 2025)

Historic Other Working Capital Changes for Whitehawk Therapeutics (WHWK) over the last 8 years, with Q3 2025 value amounting to $817000.0.

  • Whitehawk Therapeutics' Other Working Capital Changes rose 55642.46% to $817000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$297000.0, marking a year-over-year increase of 9182.94%. This contributed to the annual value of -$2.8 million for FY2024, which is 2189.84% up from last year.
  • Latest data reveals that Whitehawk Therapeutics reported Other Working Capital Changes of $817000.0 as of Q3 2025, which was up 55642.46% from -$141000.0 recorded in Q2 2025.
  • Whitehawk Therapeutics' Other Working Capital Changes' 5-year high stood at $1.6 million during Q4 2021, with a 5-year trough of -$1.7 million in Q3 2023.
  • Its 5-year average for Other Working Capital Changes is -$151421.1, with a median of -$115000.0 in 2022.
  • In the last 5 years, Whitehawk Therapeutics' Other Working Capital Changes soared by 121346.15% in 2022 and then crashed by 260363.64% in 2023.
  • Quarter analysis of 5 years shows Whitehawk Therapeutics' Other Working Capital Changes stood at $1.6 million in 2021, then tumbled by 107.01% to -$115000.0 in 2022, then plummeted by 794.78% to -$1.0 million in 2023, then surged by 79.79% to -$208000.0 in 2024, then surged by 492.79% to $817000.0 in 2025.
  • Its last three reported values are $817000.0 in Q3 2025, -$141000.0 for Q2 2025, and -$765000.0 during Q1 2025.